Trials / Completed
CompletedNCT00195286
Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.
Study of the Safety and Efficacy of Piperacillin/Tazobactam in the Treatment of Patients With Complicated Urinary Infections.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 180 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to study the efficacy of piperacillin/tazobactam in patients with complicated urinary tract infections
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | piperacillin/tazobactam |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2007-07-01
- Completion
- 2007-07-01
- First posted
- 2005-09-19
- Last updated
- 2009-09-25
Locations
27 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT00195286. Inclusion in this directory is not an endorsement.